跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NF-kappa B inhibitors (cancer)
首页
药物
NF-kappa B inhibitors (cancer)
NF-kappa B inhibitors (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of NF-kB inhibitor in treating a plurality of diseases
申请人: ZHIMIN LU
优先权: 2005
CN
Small molecule inhibitors of NF-[kappa] B-inducing kinases
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2019
CN
Substituted quinolines as improved NF-KB-induced kinase (NIK) inhibitors
申请人: NIKAIYA MEDICAL INC
优先权: 2022
CN
Simplified tripterine with anti-inflammatory and anti-cancer activity as well as preparation method and application of simplified tripterine
申请人: UNIV EAST CHINA SCIENCE & TECH
优先权: 2026
CN
药物
反馈